UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Warrants | 07/14/2014 | 07/14/2018 | Ordinary Shares | 22,374 | $ 10.08 (1) | D (2) (3) | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
SCP Vitalife Partners II LP 7 GREAT VALLEY PARKWAY SUITE 190 MALVERN, PA 19355-1446 |
 |  X |  |  |
SCP Vitalife II Associates, L.P. 7 GREAT VALLEY PARKWAY SUITE 190 MALVERN, PA 19355-1446 |
 |  X |  |  |
SCP Vitalife II GP, Ltd. 7 GREAT VALLEY PARKWAY SUITE 190 MALVERN, PA 19355-1446 |
 |  X |  |  |
CHURCHILL WINSTON J 7 GREAT VALLEY PARKWAY SUITE 190 MALVERN, PA 19355-1446 |
 |  X |  |  |
LUDOMIRSKI ABRAHAM 7 GREAT VALLEY PARKWAY SUITE 190 MALVERN, PA 19355-1446 |
 |  X |  |  |
/s/ Winston J. Churchill, attorney-in-fact | 04/20/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The Reporting Person is amending the Form 3 filed on December 31, 2015 to reflect the fact that the exercise price of the Warrants is $10.08, and not $11.45 as originally reported. |
(2) | The Warrants to purchase Ordinary Shares are directly held by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. |
(3) | The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Warrants in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest. |